Bawan Co Posts Lower Q1 Attributable Profit; Revenue Up

MT NewswiresMay 7 13:53

LifeTech Scientific Sets 2026 AGM to Renew Board, Auditor and Share Issuance Mandate

TipRanksMay 6 17:12

GF Securities: Technological breakthroughs coupled with policy support drive outstanding Q1 results for medical devices, propelled by dual engines of overseas expansion and innovation.

In recent years, the demand for domestic diagnostics has been significantly impacted by the implementation of DRG. Additionally, various regions have gradually introduced measures such as mutual recognition of hospital test results, affecting testing demand, leading to notable short-term pressure on industry demand.

Zhitong FinanceMay 6 11:21

LifeTech (1302.HK): Steady Growth in Peripheral Business and Strategic Expansion into Electrophysiology

Event: LifeTech Medical announced its 2025 annual report, stating that during the reporting period, the company achieved primary operating revenue of 1.37 billion yuan (+5.07%), net profit for the year of 112 million yuan (-33.30%), and net profit attributable to shareholders of 148 million yuan.

Northeast SecuritiesApr 26 00:00

LifeTech Seeks More Time to Restore Independent Board Compliance

TipRanksApr 24 23:14

LIFETECH SCI: ANNUAL REPORT 2025

HKEXApr 22 16:37 · Announcements